Cory Watson Crowder and DeGaris Supports New Calls for Increased Public Warnings about Potential Dangers of Pfizer Smoking Cessation Drug Chantix

Share Article

Report fuels new calls for increased public warnings about dangers of Pfizer smoking cessation drug Chantix. Deaths and record number of serious injuries reported to FDA.


Pfizer should feature a guinea pig instead of a tortoise in its advertisements for Chantix.

Law firm Cory Watson Crowder & DeGaris is urging pharmaceutical giant Pfizer Inc. to strengthen its public warnings about potentially serious or fatal injuries that may be caused by its smoking cessation drug Chantix. On October 22, 2008 the Institute for Safe Medication Practices (ISMP: released the results of an analysis performed by independent experts of adverse event reports. According to the ISMP report, Chantix accounted for more serious injuries being reported to the FDA than any other prescription drug for a second consecutive quarter. Specifically, the report says Chantix accounted for more serious injuries than all of the top ten prescription drugs combined during the first quarter of 2008, including 50 additional deaths reported.

Attorneys Kristian Rasmussen and Beth Ellis Chambers of Cory Watson Crowder & DeGaris have been investigating claims on behalf of Chantix victims for more than a year now. "Pfizer requested and received an 'expedited' review from the FDA in an effort to rush the drug onto the open market. Based on our investigation and review of information available to the public, we believe Chantix was rushed to market before it was adequately studied, placing consumers at significant risk of serious injury," said Rasmussen who continued; "Pfizer should feature a guinea pig instead of a tortoise in its advertisements for Chantix."

The FDA has already required Pfizer to strengthen the information contained in the drug label and the Federal government banned the use of Chantix by pilots and air traffic controllers. The new ISMP report urges the FDA and Pfizer to add a prominent warning about accident risks to the patient medication guide and prescribing information for doctors.

"The public needs to know all of the risks and benefits associated with using a drug like Chantix. We encourage the FDA to take a closer look what's going on," said Rasmussen who said his firm represents more than 300 Chantix victims after investigating claims from more than 2,300 individuals with inquiries about potential Chantix related injuries.    

Cory Watson Crowder & DeGaris is recognized nationally for its practice in mass torts litigation, multidistrict litigation and complex litigation including class actions, products liability, business and securities litigation, environmental litigation and mass torts litigation of defective medical devices and pharmaceuticals.

Media Contact:
Melanie McCraney


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Melaney McCraney
Visit website